LINCOLN PHARMACEUTICALS

BSE: 531633 19 Aug 2025

Healthcare

₹ 560.95

Lincoln Pharmaceuticals ltd. specializes in Pharmaceuticals within the Healthcare sector.

LINCOLN PHARMACEUTICALS

BSE: 531633 19 Aug 2025

Healthcare

₹ 560.95

Lincoln Pharmaceuticals ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

335.0

Dividend Yield

0.32%

Debt to Equity

0.0

Stock P/E

13.0

Market Cap

1,123 Cr

LINCOLN PHARMACEUTICALS - Share Price & Details

Market Cap

₹1,123

High /Low

980.0 / 499.0

Stock P/E

13.0

Book Value

₹335.0

Dividend Yield

0.32

ROCE

17.6

ROE

₹13.0

Face Value

10.0

PEG Ratio

2.1

EVEBITDA

₹8.47

Debt

0.00

CMP / FCF

27.3

Debt to equity

₹0.0

NP Ann

82.4

High price all time

980.0

Piotroski score

₹7.0

Graham Number

570.0

No. Eq. Shares

2.0

Net CF

₹7.67

Net profit

86.4

Price to book value

1.67

Interest Coverage

₹70.3

Low price all time

14.8

Industry PE

33.5

Reserves

₹652

Free Cash Flow

₹73.9

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
Shyama Computronics and Servic	1.48	0.93	0.67	0.00	5.33	35.5
Triochem Products Ltd.,	3.25	-4.52	NA	-18.44	0
LINCOLN PHARMACEUTICALS LTD.	1693.38	276.75	1540.67	13.82	1,123	13.0
Kwality Pharmaceuticals Limite	1,164.42	144.99	1,156.76	13.97	1103	25.4
KMC SPECIALITY HOSPITALS (INDI	617.27	45.22	609.35	0.27	1087	46.4

Peer Comparison Chart

About LINCOLN PHARMACEUTICALS

Lincoln Pharmaceuticals ltd., with Security Code 531633, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Has Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

(08 Aug 2025)

Most readers would already be aware that Lincoln Pharmaceuticals' (NSE:LINCOLN) stock increased significantly by 13...

355 times volume spurt: Pharma stock jumps 17.5% post Q1FY26 results; FIIs increase stake & DIIs took a fresh entry!

(08 Aug 2025)

On Thursday, shares of Lincoln Pharmaceuticals Ltd jumped 17.5 per cent to an intraday high of Rs 624.80 per share from its previous closing...

Lincoln Pharma Q1 Results: Net Profit Rises 17%

(08 Aug 2025)

Lincoln Pharmaceuticals on Thursday reported a nearly 17% growth in net profit to Rs 27.70 crore for the April-June quarter as compared to...

Lincoln Pharmaceuticals Ltd reports consolidated PAT of Rs. 27.67 crores in Q1 FY2025-26

(08 Aug 2025)

The Board of Directors of Lincoln Pharmaceuticals Limited, at its meeting held today have approved the financial results of the company for...

Lincoln Pharma re-appoints Mahendra G Patel as MD

(07 Aug 2025)

Lincoln Pharma has announced the re-appointment of Mahendra G Patel as the Managing Director of the Company for a period of five years.

Lincoln Pharma Q1 results: Profit up 17% to ₹28 cr, share jumps 8.5%

(07 Aug 2025)

Lincoln Pharmaceuticals on Thursday reported a nearly 17 per cent growth in net profit to Rs 27.70 crore for the April-June quarter as...

Quarterly Table

Standalone Consolidated

Metrics	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	112.5	135.6	156.0	146.4	142.5	147.3	161.2	146.6	168.2	154.1
Expenses	95.9	114.9	124.8	116.8	124.1	124.6	132.8	122.9	141.4	130.3
Operating Profit	16.6	20.7	31.1	29.7	18.4	22.7	28.4	23.7	26.8	23.8
OPM %	14.76%	15.28%	19.97%	20.25%	12.9%	15.43%	17.6%	16.15%	15.92%	15.45%
Other Income	3.9	7.7	8.7	11.0	7.0	10.4	10.0	9.0	-6.9	15.3
Interest	1.1	0.4	0.4	0.2	0.5	0.4	0.3	0.7	0.4	0.2
Depreciation	2.4	2.5	2.6	2.8	2.7	3.2	3.2	3.2	3.2	3.5
Profit before tax	17.0	25.4	36.9	37.7	22.2	29.5	34.8	28.7	16.3	35.4
Tax %	-26%	-25.3%	-25%	-25.6%	-16.3%	-19.7%	24.3%	-27.6%	-28.3%	21.8%
Net Profit	12.6	19.0	27.7	28.0	18.6	23.7	26.3	20.8	11.6	27.7
EPS in Rs	6.27	9.49	13.81	14	9.28	11.82	13.15	10.37	0	13.82

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	133.8	112.5	135.6	156.0	146.4	142.5	147.3	161.2	146.6	168.2
Expenses	107.0	95.8	114.9	124.8	116.8	124.1	124.6	132.8	122.9	141.4
Operating Profit	26.8	16.6	20.7	31.1	29.7	18.4	22.7	28.4	23.7	26.8
OPM %	20%	14.8%	15.28%	19.97%	20.25%	12.9%	15.43%	17.6%	16.15%	15.92%
Other Income	6.4	3.9	7.7	8.7	11.0	7.0	10.4	10.0	9.0	-6.9
Interest	0.3	1.1	0.4	0.4	0.2	0.5	0.4	0.3	0.7	0.4
Depreciation	2.3	2.4	2.5	2.6	2.8	2.7	3.2	3.2	3.2	3.2
Profit before tax	30.5	17.0	25.4	36.9	37.7	22.2	29.5	34.8	28.7	16.3
Tax %	-29.2%	-26%	-25.3%	-25%	-25.6%	-16.3%	19.7%	-24.3%	27.6%	-28.3%
Net Profit	21.6	12.6	19.0	27.7	28.0	18.6	23.7	26.3	20.8	11.6
EPS in Rs	10.79	6.27	9.49	13.81	14	9.28	11.82	13.15	10.37	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	11%
5 Years:	11%
3 Years:	10%
TTM:	7%

Compounded Profit Growth
10 Years:	19%
5 Years:	11%
3 Years:	6%
TTM:	-11%

Stock Price CAGR
10 Years:	21%
5 Years:	28%
3 Years:	25%
1 Year:	-3%

Compounded Sales Growth
10 Years:	9%
5 Years:	10%
3 Years:	10%
TTM:	7%

Compounded Profit Growth
10 Years:	19%
5 Years:	10%
3 Years:	6%
TTM:	-11%

Stock Price CAGR
10 Years:	21%
5 Years:	28%
3 Years:	25%
1 Year:	-3%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About LINCOLN PHARMACEUTICALS

Latest News

Has Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

355 times volume spurt: Pharma stock jumps 17.5% post Q1FY26 results; FIIs increase stake & DIIs took a fresh entry!

Lincoln Pharma Q1 Results: Net Profit Rises 17%

Lincoln Pharmaceuticals Ltd reports consolidated PAT of Rs. 27.67 crores in Q1 FY2025-26

Lincoln Pharma re-appoints Mahendra G Patel as MD

Lincoln Pharma Q1 results: Profit up 17% to ₹28 cr, share jumps 8.5%

Lincoln Pharma Q1 Net Profit Rises 16.93% YoY to ₹27.70 Crore

Lincoln Pharmaceuticals Reports Strong PAT and EPS Growth Amid Non-Operating Income Concerns in August 2025

Lincoln Pharma posts 17 pc jump in profit to Rs 28 cr in Apr-Jun

Lincoln Pharmaceuticals Appoints New Secretarial Auditor

गदर काट रहा है ये स्मॉलकैप फार्मा स्टॉक; अचानक से 11% की तेजी, इस ख़बर से बढ़ी इन्वेस्टर्स की रुचि

जून तिमाही में 17% बढ़ा Lincoln Pharma का मुनाफा, रेवेन्यू में भी तगड़ा उछाल

Q1 Results: Smallcap drugmaker shares surge 9% after earnings report

Lincoln Pharma Standalone June 2025 Net Sales at Rs 154.07 crore, up 4.61% Y-o-Y

Lincoln Pharmaceuticals Limited (LINCOLN) Gets Regulatory Approval - Triple-digit returns

Lincoln Pharmaceuticals Limited (531633) Expands into New Market - Consistent wealth multiplication

Lincoln Pharmaceuticals Limited (LINCOLN) vs yyy - Free Stock Market Trend Analysis

Lincoln Pharmaceuticals Limited (531633)’s Trend in 2025 - Dynamic capital growth

Lincoln Pharmaceuticals Limited (531633) Signs Major Deal - Explosive wealth accumulation

Lincoln Pharmaceuticals Limited (LINCOLN) to Launch New Product Line - Superior trading gains

Lincoln Pharmaceuticals Limited (531633)’s Trend in 2025 - Exceptional gains

Lincoln Pharmaceuticals Limited (531633) to Launch New Product Line - Phenomenal wealth increase

Lincoln Pharmaceuticals Limited (LINCOLN) vs yyy - Superior investment outcomes

Where Could Lincoln Pharmaceuticals Limited (531633) Be Headed - Market-leading capital gains

Lincoln Pharmaceuticals Faces Declining Profit Amid Shift to Mildly Bearish Trend

Lincoln Pharmaceuticals Shows Mixed Technical Trends Amidst Market Fluctuations

Lincoln Pharmaceuticals Faces Declining Profit and Market Confidence Amid Financial Adjustments

Lincoln Pharma to begin API production at Khatraj facility in 1- 2 years

Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y

Who are in the management team of Lincoln Pharma.?

How has been the historical performance of the Lincoln Pharma.?

Lincoln Pharma Sets ₹1,000 Crore Revenue Goal Within Three Years

Lincoln Pharmaceuticals targets ₹1000 crore revenues in next 3 years

Q4 Results

Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 cr

Lincoln Pharmaceuticals Faces Significant Stock Decline Amid Broader Market Challenges

Lincoln Pharmaceuticals consolidated net profit declines 37.74% in the March 2025 quarter

Lincoln Pharmaceuticals Reports Mixed Financial Results Amid Growth and Challenges in March 2025

Lincoln Pharmaceuticals Faces Continued Decline Amid Broader Market Challenges

Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) largest shareholder, Senior Key Executive Munjal Patel sees holdings value fall by 16% following recent drop

Lincoln Pharma reports standalone net profit of Rs 20.77 Cr in Q3 FY25

Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 20.77 crore in Q3 FY25

Investors Don't See Light At End Of Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Tunnel And Push Stock Down 28%

Lincoln Pharmaceuticals Faces Declining Profits Amidst Challenging Market Conditions in September 2023

NCLT Warrants Merger Of Lincoln Parenteral & Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Faces Significant Stock Volatility Amid Broader Market Stability in February 2025

Lincoln Pharmaceuticals consolidated net profit declines 25.93% in the December 2024 quarter

The total return for Lincoln Pharmaceuticals (NSE:LINCOLN) investors has risen faster than earnings growth over the last five years

Lincoln Pharmaceuticals Gains 7.83% on December 30, Outperforming Sector by 1.71%

Insider Returns Down To ₹16m As Lincoln Pharmaceuticals' Stock Dips 13%

Lincoln Pharmaceuticals Stock Declines 7.09% on December 18, 2024

Lincoln Pharmaceuticals Hits 52-Week High, Outperforms Sector and Market

Lincoln Pharmaceuticals Experiences Revision in Its Stock Evaluation Amid Strong Market Performance

723 BSE smallcap stocks end positive in the week gone by; Lincoln Pharma, HEG shine

Lincoln Pharmaceuticals' Stock Price Soars, Outperforms Sector and Sensex

Lincoln Pharmaceuticals Reaches All-Time High, Outperforms Sector and Sensex

Improved Earnings Required Before Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Stock's 39% Jump Looks Justified

Lincoln Pharmaceuticals Hits 52-Week High, Outperforms Sector with Strong Performance

Lincoln Pharmaceuticals' Stock Soars 9.67%, Outperforms Sector and Sensex

Debt-free small-cap stock Lincoln Pharma hits a lifetime high, rises over 30% in December

Lincoln Pharmaceuticals Experiences Revision in Its Stock Evaluation Amid Strong Performance Metrics

Debt-free small-cap stock Lincoln Pharma hits 20% upper circuit and a lifetime high; should you buy? | Stock Market News

Debt-free small-cap stock Lincoln Pharma hits 20% upper circuit and a lifetime high; should you buy?

Debt-Free Pharma Stock Locked At 20% Upper Circuit, FII & DII Raise Stake In Q2; Do You Own?

The stock of this Pharma Company Hits 20 per cent Upper Circuit with High Intraday Volumes; FIIs Increased their Stake in Q2 FY25

Lincoln Pharma Consolidated September 2024 Net Sales at Rs 161.21 crore, up 3.35% Y-o-Y

Lincoln Pharma Standalone September 2024 Net Sales at Rs 161.21 crore, up 3.35% Y-o-Y

Lincoln Pharmaceuticals' (NSE:LINCOLN) Earnings Are Of Questionable Quality

Lincoln Pharmaceuticals Upgraded to 'Hold' Rating by MarketsMOJO, Attractive Valuation and Institutional Investor Confidence Boost Stock

Lincoln Pharmaceuticals consolidated net profit declines 4.77% in the September 2024 quarter

Lincoln Pharmaceuticals Ltd reports Net Profit of Rs. 50.03 crore in H1 FY25, growth of 7.55 Percent Y-o-Y